I
Iovance Biotherapeutics, Inc. (IOVA)
NGM – Real Time Price. Currency in USD
3.56
-0.14 (-3.78%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
3.56
-0.14 (-3.78%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $196.5M significantly exceed its total debt $47.8M, ensuring strong financial flexibility
Total current assets $466.5M exceed Total current liabilities $129.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$78.7M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 3.60 | 6.05 | 10 | |
| Quick ratio | 3.15 | 5.63 | 10 | |
| Debt to Equity | 0.07 | 0.30 | 9.0 | |
| Debt to Assets | 0.05 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | 1M | 164M | 264M | 286M |
| Gross Profit | -21M | -32M | 18M | 54M | 71M |
| Operating Income | -399M | -461M | -395M | -398M | -358M |
| Net Income | -396M | -444M | -372M | -391M | -354M |
| EBITDA | -378M | -427M | -352M | -351M | -311M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 46.25 | 60.34 | 10 |
| Next quarter | 41.21 | 51.42 | 10 |
| Current year | 38.14 | 50.45 | 10 |
| Next year | 42.35 | 47.64 | 10 |
| Weighted average score | 10 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -17.61 | -9.92 | -5.55 | -27.13 | 1.0 |
| Y/Y | 44.82 | 31.95 | 47.22 | 28.41 | 10 |
| 3y average | 4919.53 | -0.33 | 23.74 | -3.25 | 5.5 |
| 5y average | 3351.32 | -9.69 | 8.19 | -6.61 | 4.5 |
| Weighted average score | 5.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |